EFFECTS OF HYDROXYCHLOROQUINE PLUS FAVIPIRAVIR TREATMENT ON THE CLINICAL COURSE AND BIOMARKERS IN HOSPITALIZED COVID-19 PATIENTS WITH PNEUMONIA.

Authors:
Delen LA; Gok A; Kasapoglu US; Cagasar O; Gok Z and 3 more

Journal:
Acta Clin Croat

Publication Year: 2022

DOI:
10.20471/acc.2022.61.03.05

PMCID:
PMC10364115

PMID:
37492367

Journal Information

Full Title: Acta Clin Croat

Abbreviation: Acta Clin Croat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest:: The authors have stated explicitly that there are no conflicts of interest in connection with this article."

Evidence found in paper:

"Financial disclosure:: None declared.: Funding:: This manuscript did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025